Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumour thrombus in China (2021 edition)

Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the Guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available especially for the advent of new targeted drugs and immune checkpoint inhibitor (ICIs) which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer (CALC) and Chinese Medical Doctor Association(CMDA) revised the 2018 version of guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials.
Source: Liver Cancer - Category: Cancer & Oncology Source Type: research